why choose us

First received: June 02, 2023

Clinical Trial: Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: To Reduce the LDL-C Level in Hypercholesteremia Adult Patients

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Single-blinded, Placebo-controlled, Single-ascending-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of RN0191 in Adult Subjects W

Brief Summary: Objectives: The primary and secondary objectives of the study are presented below.Exploratory objectives are presented in the body of the protocol.Primary:• To determine the safety and tolerability of RN0191 administered as escalating single subcutaneously (SC) doses in adult subjects with elevated low-density lipoprotein-cholesterolSecondary:To evaluate the single-dose pharmacokinetics (PK) of RN0191 in adult subjects with elevated low-density lipoprotein-cholesterolTo evaluate the pharmacodynamic (PD) effect of…

Read more